Cargando…
THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY
OBJECTIVE: To evaluate the effect of monosialoganglioside (GM-1) in spinal cord trauma patients seen in our service who have not been treated with methylprednisolone. METHODS: Thirty patients with acute spinal cord trauma were randomly divided into two groups. In Group 1, patients received 200 mg GM...
Autores principales: | BARROS, TARCÍSIO ELOY PESSOA, ARAUJO, FERNANDO FLORES DE, HIGINO, LUCAS DA PAZ, MARCON, RAPHAEL MARTUS, CRISTANTE, ALEXANDRE FOGAÇA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Ortopedia e Traumatologia
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863858/ https://www.ncbi.nlm.nih.gov/pubmed/27217811 http://dx.doi.org/10.1590/1413-785220162403160032 |
Ejemplares similares
-
Evaluation of the effect of intrathecal GM1 in 24, 48, and 72 hours after acute spinal cord injury in rats
por: Jorge, Daniel de Moraes Ferreira, et al.
Publicado: (2023) -
Management of patients with spinal cord injury during the coronavirus disease pandemic
por: Silva, Ricardo Teixeira e, et al.
Publicado: (2020) -
Therapeutic approaches for spinal cord injury
por: Cristante, Alexandre Fogaça, et al.
Publicado: (2012) -
Effects of ganglioside G(M1) and erythropoietin on spinal cord lesions in rats: functional and histological evaluations
por: Marcon, Raphael Martus, et al.
Publicado: (2016) -
Transdermal monosialoganglioside with laser in the treatment of spinal cord lesion in rats
por: de Souza, Fabiano Inácio, et al.
Publicado: (2013)